About: Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
Creator	Acanfora, Chiara Acanfora, Domenico Casucci, Gerardo Ciccone, Marco Scicchitano, Pietro
source	Medline; PMC
abstract	covid:8913ef3c6de95c2bacf8e0c9af842f9238c7f344#abstract
has issue date	2020-04-13(xsd:dateTime)
bibo:doi	10.1093/ehjcvp/pvaa028
bibo:pmid	32282032
has license	no-cc
sha1sum (hex)	8913ef3c6de95c2bacf8e0c9af842f9238c7f344
schema:url	https://doi.org/10.1093/ehjcvp/pvaa028
resource representing a document's title	Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
has PubMed Central identifier	PMC7184416
has PubMed identifier	32282032
schema:publication	Eur Heart J Cardiovasc Pharmacother
resource representing a document's body	covid:8913ef3c6de95c2bacf8e0c9af842f9238c7f344#body_text
is schema:about of	named entity 'sacubitril/valsartan' named entity 'angiotensin II receptor blocker' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity '11 March 2020' named entity 'neutrophil' named entity 'biological plausibility' named entity 'Ang II' named entity 'ACE2' named entity 'sacubitril' named entity 'ACE2' named entity 'virus' named entity 'hypertensive' named entity 'anti-inflammatory' named entity 'viral infection' named entity 'vasodilator' named entity 'Lymphocyte count' named entity 'coronavirus' named entity 'receptor' named entity 'Severe acute respiratory syndrome' named entity 'virus' named entity 'receptor' named entity 'pathology' named entity 'lymphocyte count' named entity 'endothelin' named entity 'ACE2' named entity 'World Health Organization' named entity 'SARS-CoV-2 virus' named entity 'vasoconstriction' named entity 'ACE2' named entity 'COVID' named entity 'COVID' named entity 'peptidase' named entity 'receptor' named entity 'sacubitril/valsartan' named entity 'angiotensin' named entity 'WHO' named entity 'valsartan' named entity 'COVID' named entity 'receptor' named entity 'COVID-19' named entity 'up-regulate' named entity 'COVID-19' named entity 'high sensitivity C-reactive protein' named entity 'SARS-CoV-2' named entity 'lymphocytes' named entity 'Ang II' named entity 'lymphocyte count' named entity 'neprilysin' named entity 'angiotensin' named entity 'receptor' named entity 'ACE2' named entity 'ACE2' named entity 'ACE2' named entity 'angiotensin-converting enzyme 2' named entity 'sacubitril/valsartan' named entity 'SARS-CoV-2' named entity 'vascular permeability' named entity 'angiotensin' named entity 'angiotensin' named entity 'Ang II' named entity 'antivirals' named entity 'sacubitril/valsartan' named entity 'vaccine' named entity 'COVID-19' named entity 'angiotensin' named entity 'sacubitril' named entity 'physiological functions' named entity 'placebo' named entity 'COVID' named entity 'cell membrane' named entity 'down-regulation' named entity 'tocilizumab' named entity 'acute heart failure' named entity 'lymphocyte count' named entity 'angiotensin' named entity 'C-type natriuretic peptide'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software